Suivre
Alberto Bossi
Alberto Bossi
Affiliation inconnue
Adresse e-mail validée de igr.fr
Titre
Citée par
Citée par
Année
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a …
ED Kwon, CG Drake, HI Scher, K Fizazi, A Bossi, AJM Van den Eertwegh, ...
The lancet oncology 15 (7), 700-712, 2014
16122014
Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
S Gillessen, G Attard, TM Beer, H Beltran, A Bossi, R Bristow, B Carver, ...
European urology 73 (2), 178-211, 2018
5332018
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label …
K Fizazi, S Foulon, J Carles, G Roubaud, R McDermott, A Fléchon, ...
The Lancet 399 (10336), 1695-1707, 2022
4782022
Oral relugolix for androgen-deprivation therapy in advanced prostate cancer
ND Shore, F Saad, MS Cookson, DJ George, DR Saltzstein, R Tutrone, ...
New England Journal of Medicine 382 (23), 2187-2196, 2020
3882020
Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature
P Ost, A Bossi, K Decaestecker, G De Meerleer, G Giannarini, RJ Karnes, ...
European urology 67 (5), 852-863, 2015
3882015
Management of patients with advanced prostate cancer: report of the advanced prostate cancer consensus conference 2019
S Gillessen, G Attard, TM Beer, H Beltran, A Bjartell, A Bossi, A Briganti, ...
European urology 77 (4), 508-547, 2020
3822020
Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature
L Budäus, M Bolla, A Bossi, C Cozzarini, J Crook, A Widmark, T Wiegel
European urology 61 (1), 112-127, 2012
3492012
Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group
P Poortmans, A Bossi, K Vandeputte, M Bosset, R Miralbell, P Maingon, ...
Radiotherapy and Oncology 84 (2), 121-127, 2007
3412007
Radiotherapy for renal-cell carcinoma
G De Meerleer, V Khoo, B Escudier, S Joniau, A Bossi, P Ost, A Briganti, ...
The Lancet Oncology 15 (4), e170-e177, 2014
3122014
Brachytherapy: An overview for clinicians
C Chargari, E Deutsch, P Blanchard, S Gouy, H Martelli, F Guérin, ...
CA: a cancer journal for clinicians 69 (5), 386-401, 2019
2872019
EAU-EANM-ESTRO-ESUR-SIOG prostate cancer guideline panel consensus statements for deferred treatment with curative intent for localised prostate cancer from an international …
TBL Lam, S MacLennan, PPM Willemse, MD Mason, K Plass, R Shepherd, ...
European urology 76 (6), 790-813, 2019
2402019
ESTRO ACROP consensus guideline on CT-and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer
C Salembier, G Villeirs, B De Bari, P Hoskin, BR Pieters, M Van Vulpen, ...
Radiotherapy and Oncology 127 (1), 49-61, 2018
2202018
Guidelines for primary radiotherapy of patients with prostate cancer
D Boehmer, P Maingon, P Poortmans, MH Baron, R Miralbell, ...
Radiotherapy and oncology 79 (3), 259-269, 2006
2052006
EAU-ESMO Consensus statements on the management of advanced and variant bladder cancer—an international collaborative multistakeholder effort†: under the auspices of the EAU …
JA Witjes, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, ...
European urology 77 (2), 223-250, 2020
1912020
High-risk prostate cancer: from definition to contemporary management
PJ Bastian, SA Boorjian, A Bossi, A Briganti, A Heidenreich, SJ Freedland, ...
European urology 61 (6), 1096-1106, 2012
1722012
Photophysical properties of cyclometalated pt (II) complexes: counterintuitive blue shift in emission with an expanded ligand π system
A Bossi, AF Rausch, MJ Leitl, R Czerwieniec, MT Whited, PI Djurovich, ...
Inorganic Chemistry 52 (21), 12403-12415, 2013
1632013
Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N-or NX)
R de Crevoisier, K Slimane, N Sanfilippo, A Bossi, M Albano, I Dumas, ...
International Journal of Radiation Oncology* Biology* Physics 74 (4), 1150-1156, 2009
1572009
A systematic review of hypofractionation for primary management of prostate cancer
BF Koontz, A Bossi, C Cozzarini, T Wiegel, A D’Amico
European urology 68 (4), 683-691, 2015
1492015
Risks from deferring treatment for genitourinary cancers: a collaborative review to aid triage and management during the COVID-19 pandemic
CJD Wallis, G Novara, L Marandino, A Bex, AM Kamat, RJ Karnes, ...
European urology 78 (1), 29-42, 2020
1472020
Final analysis of the ipilimumab versus placebo following radiotherapy phase III trial in postdocetaxel metastatic castration-resistant prostate cancer identifies an excess of …
K Fizazi, CG Drake, TM Beer, ED Kwon, HI Scher, WR Gerritsen, A Bossi, ...
European urology 78 (6), 822-830, 2020
1432020
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20